Outlook for the next 5 years in drug innovation
Nature Reviews Drug Discovery 11,435 (2012).
doi:10.1038/nrd3744
Authors:Roy Berggren,Martin Møller,Rachel Moss,Pawel Poda &Katarzyna Smietana
Analysis of industry pipeline data and revenue forecasts highlights several trends in the anticipated output of new drugs and the therapeutic area focus over the next 5 years,including a growth in the average number of new drug approvals annually.
Nature Reviews Drug Discovery –Issue –nature.com science feeds
